114 related articles for article (PubMed ID: 36974831)
1. The Prognostic Role of ACO2 in Renal Cell Carcinoma.
Jaworski D; Kowalewski A; Durślewicz J; Antosik P; Smolińska M; Grzanka D; Szylberg Ł
Anticancer Res; 2023 Apr; 43(4):1503-1511. PubMed ID: 36974831
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.
Wang P; Mai C; Wei YL; Zhao JJ; Hu YM; Zeng ZL; Yang J; Lu WH; Xu RH; Huang P
Med Oncol; 2013 Jun; 30(2):552. PubMed ID: 23550275
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
4. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of PYCR1 expression in renal cell carcinoma.
Weijin F; Zhibin X; Shengfeng Z; Xiaoli Y; Qijian D; Jiayi L; Qiumei L; Yilong C; Hua M; Deyun L; Jiwen C
Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.
Rausch S; Beermann J; Scharpf M; Hennenlotter J; Fend F; Stenzl A; Schollenberger D; Bedke J; Kruck S
World J Urol; 2016 Dec; 34(12):1635-1641. PubMed ID: 26995391
[TBL] [Abstract][Full Text] [Related]
9. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Xiong L; Li D; Zou Q; Yuan Y
Int J Clin Oncol; 2020 Jul; 25(7):1346-1355. PubMed ID: 32249333
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
[TBL] [Abstract][Full Text] [Related]
11. TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma.
Kowalewski A; Jaworski D; Borowczak J; Maniewski M; Szczerbowski K; Antosik P; Durślewicz J; Smolińska M; Ligmanowska J; Grzanka D; Szylberg Ł
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499030
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
[TBL] [Abstract][Full Text] [Related]
14. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
15. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
18. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
Ho TH; Serie DJ; Parasramka M; Cheville JC; Bot BM; Tan W; Wang L; Joseph RW; Hilton T; Leibovich BC; Parker AS; Eckel-Passow JE
Ann Oncol; 2017 Mar; 28(3):604-610. PubMed ID: 27993815
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
